↓ Skip to main content

The expanding role of primary care in cancer control

Overview of attention for article published in Lancet Oncology, September 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

14 news outlets
1 blog
1 policy source
42 tweeters
1 Facebook page
1 Google+ user


164 Dimensions

Readers on

328 Mendeley
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
The expanding role of primary care in cancer control
Published in
Lancet Oncology, September 2015
DOI 10.1016/s1470-2045(15)00205-3
Pubmed ID

Greg Rubin, Annette Berendsen, S Michael Crawford, Rachel Dommett, Craig Earle, Jon Emery, Tom Fahey, Luigi Grassi, Eva Grunfeld, Sumit Gupta, Willie Hamilton, Sara Hiom, David Hunter, Georgios Lyratzopoulos, Una Macleod, Robert Mason, Geoffrey Mitchell, Richard D Neal, Michael Peake, Martin Roland, Bohumil Seifert, Jeff Sisler, Jonathan Sussman, Stephen Taplin, Peter Vedsted, Teja Voruganti, Fiona Walter, Jane Wardle, Eila Watson, David Weller, Richard Wender, Jeremy Whelan, James Whitlock, Clare Wilkinson, Niek de Wit, Camilla Zimmermann


The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care-its continuous, coordinated, and comprehensive care for individuals and families-are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.

Twitter Demographics

The data shown below were collected from the profiles of 42 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 328 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Spain 2 <1%
New Zealand 2 <1%
Jamaica 1 <1%
Canada 1 <1%
Ecuador 1 <1%
United States 1 <1%
Unknown 317 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 61 19%
Student > Ph. D. Student 49 15%
Student > Master 47 14%
Other 32 10%
Student > Bachelor 31 9%
Other 108 33%
Readers by discipline Count As %
Medicine and Dentistry 147 45%
Unspecified 45 14%
Nursing and Health Professions 35 11%
Social Sciences 19 6%
Agricultural and Biological Sciences 18 5%
Other 64 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 138. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2019.
All research outputs
of 13,457,898 outputs
Outputs from Lancet Oncology
of 4,835 outputs
Outputs of similar age
of 247,875 outputs
Outputs of similar age from Lancet Oncology
of 153 outputs
Altmetric has tracked 13,457,898 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,835 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,875 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.